Mangalam Organics Ltd

BSE Code : 514418
NSE Symbol : MANORG
ISIN : INE370D01013
Industry :CHEMICALS

Trade Now

Get Quotes

567.00 -4.50(-0.79%)

Open Price (₹)

580.00

Prev. Close (₹)

571.50

Volume (No’s)

1,313

Market Cap (₹)

485.60

Low Price (₹)

565.00

High Price (₹)

580.00 Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Board Meetings

Start Date	End Date	Purpose
13-Aug-2025	18-Aug-2025	Inter alia, to consider and approve the proposal for fund raising by issue of securities on Private Placement basis. The Board of Directors of the Company, at its meeting held today, i.e., August 18, 2025, inter alia, considered and approved the issuance, by way of private placement, of Secured, Unlisted, Unrated, Senior Non-Convertible Debentures (NCDs) aggregating up to INR 60 crores in terms of applicable provisions of the Companies Act, 2013 and other applicable laws. (As per BSE Announcement Dated on 18.08.2025)
01-Aug-2025	08-Aug-2025	Mangalam Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 inter alia to consider and approve We wish to inform you that the Board Meeting of the Company is scheduled to be held on August 08 2025 for the purpose of consideration of Unaudited Standalone and Consoliadted Financial statements of the Company for the quarter ended June 30 2025 and any other business with the permission of the chairperson. The Board at its meeting held today, has considered and approve the following matters: 1. Unaudited Standalone and Consolidated Financial Statements for the quarter ended June 30, 2025 2. Date of 43rd Annual General Meeting of the Company, draft Board Report along with the cut off date and book closure 3. Updation of Code under Prevention of Insider Trading Regulations 4. Appointment of Auditors and Re-appointment of Directors . The Board at its meeting held today, has considered and approved the following matters: 1. Unaudited Standalone and Consolidated Financial Statements for the quarter ended June 30, 2025. 2. Date of 43rd Annual General Meeting of the Company, draft Board report along with the Cut- off date and book closure 3. Updation of Code under Insider Trading Regulations 4. Appointment of Auditors and Re-appointment of Directors . Please find the Unaudited Standalone and Consolidated Financial Statements of the Company for the quarter ended June 30, 2025 (As per BSE Announcement Dated on 08.08.2025)
03-May-2025	10-May-2025	Mangalam Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2025 inter alia to consider and approve Pursuant to Regulation 29 and 30 of the Listing Regulations we wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Saturday May 10 2025 inter alia to consider and approve the following: 1. Audited Standalone and Consolidated Financial Statements of the Company under Indian Accounting Standards (Ind- AS) for the fourth quarter and year ended March 31 2025. 2. To consider any other business with the permission of the Chair. Pursuant to Regulation 30 and 33 of the Listing Regulations, Approved the Audited Standalone and Consolidated Financial Statements for the Fourth quarter and year ended March 31, 2025. In this regard, please find enclosed: Audited Standalone and Consolidated Financial Statements of the Company for the Fourth quarter and year ended March 31, 2025, which had been duly reviewed and recommended by the Audit Committee along with the Auditor's Report with Unmodified opinion thereon. (As Per BSE Announcement Dated on: 10/05/2025)
31-Jan-2025	07-Feb-2025	Quarterly Results We wish to inform you that the Board at its meeting held today, has considered and approved the appointment of Mr. Mahesh Navathar as an Additional Executive Director of Works of the Company subject to the approval of Shareholders by Postal Ballot activity through Remote E-voting. (As per BSE Announcement Dated on 07/02/2025)
30-Oct-2024	08-Nov-2024	Mangalam Organics Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results and Limited Review Report for the second quarter and Half year ended September 30 2024. We hereby inform you that the Board at its meeting held today, i.e. Friday, November 08, 2024 Inter alia, considered and approved the following: a)Unaudited Standalone and Consolidated Financial Statements of the Company for the Second quarter and Half year ended September 30, 2024, which had been duly reviewed and recommended by the Audit Committee. b)The Limited Review Report in respect of the Unaudited Standalone and Consolidated Financial Statements of the Company for Second quarter and Half year ended September 30, 2024. The Meeting commenced at 03:00 p.m. (IST) and concluded at 04:30 p.m. (IST) (As per BSE Announcement Dated on 08/11/2024)